Blogs
Rosalind Franklin: Unveiling the DNA Helix and Beyond Her name is Rosalind Franklin. Her crucially important X-ray crystallography work was key to the formulation of an accurate description of the double-helical structure of DNA Born on July 25, 1920, in London,…
May 7
- May 11
The American Society of Gene & Cell Therapy (ASGCT) annual meeting is the premier gathering for scientists, physicians, industry leaders, and patient advocates working at the forefront of gene and cell therapy. This year’s meeting, taking place in Baltimore, MD from May 7th to 11th, 2024, promises to be…
March 21
- March 21
The Boston Society Gene & Cell Therapy Conference, renowned for its focus on translating groundbreaking scientific ideas into practical industrial applications, returns for another enriching gathering. This year’s event promises to be an invaluable platform for researchers, engineers, and industry leaders to connect, share knowledge, and shape the future…
webinars
Produced by Bioanalysis Zone Recorded on December 11, 2023 Webinar available here. Webinar Description: In this webinar, Dominic Warrino discusses the bioanalytical considerations of immunogenicity of cell and gene therapies. Bioanalysis method development and method validation of immunogenicity assays for support of cell and…
Blogs
Recently, Matthew Pennington, PhD (one of KCAS’s Senior Scientists) was the senior author on a publication entitled “A Validated Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno Associated Viral Vectors in Bio Shedding Studies of Tears”. Below, Matt explains the significance in what they accomplished…
Special guest Carrie Vyhlidal, PhD of KCAS Bio joins John and Dom in the 68th episode of “The Weekly Bioanalysis” to discuss the ways molecular cell & gene therapy services has evolved and why their role will likely become more and more important to the world of bioanalytical…
Biologics are drugs derived from complex molecules like antibodies. Over the last two decades they have re-emerged…
Being that it is a relatively “niche” segment of the industry, there are several key areas that need to be considered in the field of molecular services related to cell and gene therapies. First and foremost, it is important to recognize that regulatory guidelines within this field are…
Cell and Gene Therapies (CGTs) has an estimated market size value in 2022 of USD 8.22 billion and a revenue forecast in 2030 of USD 24.5 billion. This is a CAGR (compound annual growth rate) of 14.6% from 2022 to 2030. Needless to say, the…
With the extensive advances in technologies like CRISPR and CAR-T, cell and gene therapy has grown to become a viable way for treating Cancer as well as other diseases. Our team has over 100+ years of collective expertise in molecular services using qPCR and ddPCR for support of…
Being produced by Xtalks on Friday, June 24, 2022 | 12pm EDT (NA) / 5pm BST (UK) / 6pm CEST (EU-Central) 60 min Webinar Description: Cell and gene therapies (CGTs) are types of treatment that use cellular or genetic material with the goal of treating a disease or a…